Autologous lymphocyte infusion
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Autologous lymphocyte infusion, covering 2012-12-21 to 2025-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Teclistamab Plus Autologous Lymphocyte Infusion (ALI) for the Treatment of R/R Multiple Myeloma [Phase 2]